ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board americanpharmaceuticalreview
August 11, 2021MindMed, a biotech company developing psychedelic-inspired therapies, announced the addition of Robert H. Dworkin, Ph.D. to its Scientific Advisory Board. Dr. Dworkin has spent over 35 years conducting clinical research on pain.
Pharma Sources Insight January 2025
